GLP-2 levels in infants with intestinal dysfunction.

Area of Science:

• Pediatric Gastroenterology
• Endocrinology
• Surgical Outcomes

Background:

• Glucagon Like Peptide 2 (GLP-2) is implicated in nutrient absorption.
• Infants with intestinal dysfunction post-surgery present challenges in nutrient absorption and feeding tolerance.
• The role of GLP-2 in pediatric intestinal dysfunction is not fully understood.

Purpose of the Study:

• To correlate postprandial GLP-2 levels with intestinal length, nutrient absorption, and patient outcomes in infants with intestinal dysfunction.
• To determine if GLP-2 levels can predict the ability to wean from total parenteral nutrition (TPN) and tolerance of enteral feeding.

Main Methods:

• Prospective monitoring of 12 infants with nutrient malabsorption post-intestinal surgery.
• Measurement of postprandial GLP-2 levels after feeding initiation.
• Quantification of nutrient absorption using balance studies and carbohydrate probe methods.
• Intraoperative measurement of intestinal length.

Main Results:

• GLP-2 levels strongly correlated with residual small intestinal length (r² = 0.75).
• Contrary to hypothesis, GLP-2 levels positively correlated with fat (r² = 0.72), carbohydrate (0.50), and protein (0.54) absorption.
• A postprandial GLP-2 level of 15 pmol/L differentiated infants who could be weaned from TPN.
• Infants with GLP-2 > 15 pmol/L were successfully weaned; 3 of 4 with GLP-2 < 15 pmol/L could not be weaned by one year.

Conclusions:

• In infants with intestinal dysfunction, GLP-2 levels are linked to residual small bowel length and nutrient absorption capacity.
• Postprandial GLP-2 levels may serve as a predictive marker for TPN weaning and feeding tolerance in this population.
• Infants with short bowel syndrome (SBS) and an intact colon may not produce GLP-2 in response to feeding, unlike adults.